Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm

ClinicalTrials.gov ID: NCT04503551

Public ClinicalTrials.gov record NCT04503551. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 7:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multicenter, Randomized Study of the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Patients With Diabetic Retinopathy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study GR41675 is a Multicenter, Randomized Study in Participants with Diabetic Retinopathy (DR) Without Center-Involved Diabetic Macular Edema (CI-DME) to Evaluate the Efficacy, Safety of the Port Delivery System with Ranibizumab (PDS) Relative to the Comparator Arm

Study identification

NCT ID
NCT04503551
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
174 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 10, 2020 (Actual)
Primary completion
Oct 3, 2022 (Actual)
Completion
Feb 23, 2026 (Actual)
Last update posted
Apr 2, 2026

2020 – 2026

United States locations

U.S. sites
64
U.S. states
28
U.S. cities
62
Facility City State ZIP Site status
Barnet Dulaney Perkins Eye Center Mesa Arizona 85206 —
Retinal Consultants of Arizona;Opthalmology Phoenix Arizona 85014 —
Associated Retina Consultants Phoenix Arizona 85020 —
California Retina Consultants Bakersfield California 93309 —
The Retina Partners Encino California 91436 —
Retina Consultants of Orange County;Clinical Research Fullerton California 92835 —
Jules Stein Eye Institute/ UCLA Los Angeles California 90095 —
California Eye Specialists Medical Group Pasadena California 91107 —
Kaiser Permanente;RESEARCH AND EVALUATION Riverside California 92505 —
Retina Consultants Medical Group Sacramento California 95841 —
Orange County Retina Medical Group Santa Ana California 92705 —
Southwest Retina Research Center Durango Colorado 81303 —
Colorado Clinical Research Lakewood Colorado 80228 —
Retina Group of New England Waterford Connecticut 06385 —
Retina Specialty Institute Pensacola Florida 32503 —
Fort Lauderdale Eye Institute Plantation Florida 33324 —
Retina Associates of Florida;Retina Associates of Florida Tampa Florida 33609 —
Southeast Retina Center Augusta Georgia 30909 —
Georgia Retina Marietta Georgia 30060 —
Retina Consultants of Hawaii at Pali Momi Medical Center ‘Aiea Hawaii 96701 —
Northwestern Memorial Hospital Chicago Illinois 60611 —
Illinois Retina Associates Joliet Illinois 60435 —
University Retina Lemont Illinois 60439 —
Retina Associates Lenexa Kansas 66215 —
Maine Eye Center Portland Maine 04605 —
The Retina Care Center Baltimore Maryland 21209 —
Johns Hopkins Hospital;Johns Hopkins Med;Wilmer Eye Inst Baltimore Maryland 21287 —
Cumberland Valley Retina Consultants;Clinical Research Hagerstown Maryland 21740 —
Associated Retinal Consultants - Royal Oak Royal Oak Michigan 48073 —
VitreoRetinal Surgery PLLC;DBA Retina Consultants of Minnesota Minneapolis Minnesota 55435 —
Pepose Vision Institute Chesterfield Missouri 63017 —
Sierra Eye Associates Reno Nevada 89502 —
Envision Ocular, LLC Bloomfield New Jersey 07003 —
Retina Associates of New Jersey Teaneck New Jersey 07666 —
Retina Vitreous Surgeons of Central New York Liverpool New York 13088 —
New York University (NYU) New York New York 10012 —
Asheville Eye Associates Western Carolina Retinal Associates;Clinical Research Asheville North Carolina 28803 —
Charlotte Eye Ear Nose and Throat Associates- SouthPark;Retina Charlotte North Carolina 28210 —
Duke Eye Center Durham North Carolina 27705 —
Cape Fear Retinal Associates Wilmington North Carolina 28401 —
Ohio State Havener Eye Institute;Ophthalmology Research Columbus Ohio 43212 —
Retina Vitreous Center - Glen Eagles Edmond Oklahoma 73013 —
Retina Northwest;Research Department Portland Oregon 97221 —
Mid Atlantic Retina;Retina Research Philadelphia Pennsylvania 19107 —
Charleston Neuroscience Ladson South Carolina 29456 —
Palmetto Retina Center West Columbia South Carolina 29169 —
Charles Retina Institution;Retina surgery Germantown Tennessee 38138 —
Southeastern Retina Associates Knoxville Tennessee 37922 —
Tennessee Retina Nashville Tennessee 37203 —
Retina Research Institute of Texas Abilene Texas 79606 —
Austin Retina Associates;Opthalmology Austin Texas 78705 —
Retina & Vitreous of Texas Bellaire Texas 77401 —
Texas Retina Associates;Research Dallas Texas 75231 —
Retina Center of Texas Grapevine Texas 76051 —
Retina Consultants of Texas Houston Texas 77401 —
Medical Center Ophthalmology Associates San Antonio Texas 78240 —
Retina Consultants of Texas The Woodlands Texas 77384 —
Rocky Mountain Retina Consultants Murray Utah 84107 —
Retina Associates of Utah, PLLC;Clinical Research Salt Lake City Utah 84107 —
Piedmont Eye Center Lynchburg Virginia 24502 —
Wagner Kapoor Institute;Opthalmology Norfolk Virginia 23502 —
Retina Institute of Virginia Richmond Virginia 23235 —
Pacific Northwest Retina Silverdale Washington 98383 —
Spokane Eye Clinical Research;Spokane Eye Surgery Center Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04503551, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 2, 2026 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04503551 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →